ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $97,000 | -78.9% | 2,854 | -79.6% | 0.00% | -100.0% |
| Q3 2015 | $459,000 | -55.6% | 14,002 | -28.2% | 0.00% | -50.0% |
| Q2 2015 | $1,033,000 | +17.5% | 19,501 | -36.0% | 0.00% | 0.0% |
| Q1 2015 | $879,000 | -28.5% | 30,448 | -28.2% | 0.00% | 0.0% |
| Q4 2014 | $1,229,000 | – | 42,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |